Market Rank #46 · Evidence Tier A

Thailand
Neuroscience Intelligence

Thailand neuroscience intelligence: 37 indexed trials, 15 institutions, research score 27.45.

⚗
37Indexed trials
↗
11Recruiting
⌂
15Research institutions
◎
27.4Research score

Evidence profile

21Sponsors
10Disease areas
0Institution works
0Institution citations

Evidence signals

Research score 27.4 · Data confidence 100.00 · Evidence 27.4

Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.

Leading disease areas

parkinsons15trials
epilepsy7trials
stroke6trials
multiple_sclerosis2trials
pain_neuropathy2trials
movement_disorders1trials
anxiety1trials
autism1trials
depression1trials
als1trials

Leading indexed sponsors

Merck Sharp & Dohme LLC10trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials
Chulalongkorn University2trials
UCB Pharma2trials
Mahidol University2trials
Department of Medical Services Ministry of Public Health of Thailand2trials
Khon Kaen University1trials
International Rescue Committee1trials
Medtronic Neurovascular Clinical Affairs1trials
IRCCS San Raffaele Roma1trials